Upcoming events
EFMC International Symposium on Medicinal Chemistry 2026
In person
At the upcoming EFMC conference in Basel, Masakazu Kobayashi | LinkedIn, Head of Assay Development and Screening at ZoBio, will present the poster:
Tailor-made Biophysics – A Versatile Toolkit for Discovery and Validation.
The poster will showcase selected case studies demonstrating how flexible biophysical strategies can help address diverse discovery challenges from fragment-based screening for molecular glues and the profiling of covalent compounds to the characterization of antibody–antigen interactions and the generation of structural models when X-ray crystallography reaches its limits.
Heading to EFMC Basel and want to know more? We would love to connect.
10th RSC-BMCS Fragment-based Drug Discovery Meeting
In person
ZoBio is pleased to attend the RSC-BMCS Fragment-Based Drug Discovery meeting in Cambridge this September.
ZoBio will be represented by Johan Veerman | LinkedIn, Head of Chemistry, who will also present a poster entitled:
Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14
We look forward to sharing our work, exchanging ideas with the fragment-based drug discovery community, and connecting with fellow scientists in Cambridge.
Discovery on Target
In person
ZoBio will participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small molecules.
Gregg Siegal | LinkedIn, CEO of ZoBio, will present the poster titled Biophysics-driven Molecular Glue Discovery.
Have a drug discovery challenge? Let’s talk about how we can help move your project forward.
16th Swiss Course on Medicinal Chemistry in Leysin
In person
As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin!
This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies and technologies that support hit generation, lead finding, and lead optimization campaigns.
Also our scientists are excited to contribute to this special event. On Thursday, October 8th, Stephan Theisgen | LinkedIn will present a talk on the application of NMR in modern drug discovery. Additionally, Marta G. Carneiro | LinkedIn (Head of Structural Biology) and Johan Veerman | LinkedIn (Head of Chemistry) will share their expertise on the use of biophysics in various aspects of drug discovery with the next generation of drug hunters.
Looking forward to meeting you in Leysin!